U.S. and E.U. cardiologists call for a hard check on global sales of renal denervation technology in the wake of Medtronic's disappointing SYMPLICITY HTN-3 study.
MASSDEVICE ON CALL — A group of cardiologists is taking a hard stance against renal denervation, calling for medical device manufacturers to stop selling the technology as a treatment for hypertension.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qkDfD7
Cap comentari:
Publica un comentari a l'entrada